Inflammatory mechanisms in COVID-19 and atherosclerosis: current pharmaceutical perspectives
Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has been associated with excess mortality worldwide. The …
coronavirus 2 (SARS-CoV-2) has been associated with excess mortality worldwide. The …
KG-COVID-19: a framework to produce customized knowledge graphs for COVID-19 response
Integrated, up-to-date data about SARS-CoV-2 and COVID-19 is crucial for the ongoing
response to the COVID-19 pandemic by the biomedical research community. While rich …
response to the COVID-19 pandemic by the biomedical research community. While rich …
COVID-19's immuno-pathology and cardiovascular diseases
The pandemic of COVID-19 in worldwide causes recent millions of morbidity and mortality in
all countries and is the most important challenge in the world in recent years. Coronavirus is …
all countries and is the most important challenge in the world in recent years. Coronavirus is …
[HTML][HTML] Spillover effects of COVID-19 on essential chronic care and ways to foster health system resilience to support vulnerable non-COVID patients: a …
Objectives Little empirical research exists on how key stakeholders involved in the provision
of care for chronic conditions and policy planning perceive the indirect or “spillover” effects …
of care for chronic conditions and policy planning perceive the indirect or “spillover” effects …
Impact of COVID-19 infection on the cardiovascular system: An evidence-based analysis of risk factors and outcomes
AD Kaye, AL Spence, M Mayerle, N Sardana… - Best Practice & …, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as COVID-19,
emerged in late 2019 in Wuhan, China. The World Health Organization declared the virus a …
emerged in late 2019 in Wuhan, China. The World Health Organization declared the virus a …
[HTML][HTML] Lung opacity and coronary artery calcium score: a combined tool for risk stratification and outcome prediction in COVID-19 patients
V Koch, LD Gruenewald, MH Albrecht, K Eichler… - Academic …, 2022 - Elsevier
Purpose To assess and correlate pulmonary involvement and outcome of SARS-CoV-2
pneumonia with the degree of coronary plaque burden based on the CAC-DRS …
pneumonia with the degree of coronary plaque burden based on the CAC-DRS …
The COVID-19 vaccine preference for youngsters using promethee-ii in the ifss environment
Extensive decision-making during the vaccine preparation period is unpredictable. An
account of the severity of the disease, the younger people with COVID-19 comorbidities and …
account of the severity of the disease, the younger people with COVID-19 comorbidities and …
Host cell stress response as a predictor of COVID-19 infectivity and disease progression
C Caillet, ML Stofberg, V Muleya, A Shonhai… - Frontiers in Molecular …, 2022 - frontiersin.org
The coronavirus disease (COVID-19) caused by a coronavirus identified in December 2019
has caused a global pandemic. COVID-19 was declared a pandemic in March 2020 and has …
has caused a global pandemic. COVID-19 was declared a pandemic in March 2020 and has …
Social determinants of adherence to COVID-19 risk mitigation measures among adults with cardiovascular disease
KK Hagan, Z Javed, M Cainzos-Achirica… - … Quality and Outcomes, 2021 - Am Heart Assoc
Background: Social determinants of health (SDOH) may limit the practice of coronavirus
disease 2019 (COVID-19) risk mitigation guidelines with health implications for individuals …
disease 2019 (COVID-19) risk mitigation guidelines with health implications for individuals …
Role of ACE2-Ang (1–7)-Mas axis in post-COVID-19 complications and its dietary modulation
Severe acute respiratory syndrome-coronavirus-2 (COVID-19) virus uses Angiotensin-
Converting Enzyme 2 (ACE2) as a gateway for their entry into the human body. The ACE2 …
Converting Enzyme 2 (ACE2) as a gateway for their entry into the human body. The ACE2 …